Indeed, therapeutic strategies to inhibit neutrophil recruitment in inflammatory and autoimmune disease by blocking CD11b has been beneficial in some experimental models, but has not been as successful as a therapeutic in human clinical trials [12]. The gene discussed is ITGAM; the disease is autoimmune disease.